KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Cash & Equivalents (2016 - 2025)

Elevance Health (ELV) has disclosed Cash & Equivalents for 17 consecutive years, with $9.5 billion as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 14.51% to $9.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.5 billion through Dec 2025, up 14.51% year-over-year, with the annual reading at $9.5 billion for FY2025, 14.51% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $9.5 billion at Elevance Health, up from $8.7 billion in the prior quarter.
  • The five-year high for Cash & Equivalents was $10.9 billion in Q3 2023, with the low at $4.9 billion in Q4 2021.
  • Average Cash & Equivalents over 5 years is $7.7 billion, with a median of $7.7 billion recorded in 2024.
  • The sharpest move saw Cash & Equivalents soared 74.48% in 2021, then plummeted 38.61% in 2024.
  • Over 5 years, Cash & Equivalents stood at $4.9 billion in 2021, then soared by 51.37% to $7.4 billion in 2022, then decreased by 11.66% to $6.5 billion in 2023, then grew by 27.0% to $8.3 billion in 2024, then increased by 14.51% to $9.5 billion in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $9.5 billion, $8.7 billion, and $8.6 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.